Advantest (FRA:VANA) Other Stockholders Equity: €544 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:VANA Advantest Corp FRA:VANA
87 GF Score
Price €167.00
GF Value €84.37
Valuation Significantly Overvalued
! 4 Warning Signs
View Full Analysis

What is Advantest Other Stockholders Equity?

Advantest FRA:VANA +5.03% 87 Other Stockholders Equity is €544 Mil as of Mar. 2026. GuruFocus rates FRA:VANA with a GF Score™ of 87/100 and a GF Value™ of €84.37 (Significantly Overvalued). The stock has 4 warning signs investors should review.

Advantest's Other Stockholders Equity for the quarter that ended in Mar. 2026 was €544 Mil.

Advantest's quarterly Other Stockholders Equity increased from Sep. 2025 (€336 Mil) to Dec. 2025 (€477 Mil) and increased from Dec. 2025 (€477 Mil) to Mar. 2026 (€544 Mil).

Advantest's annual Other Stockholders Equity declined from Mar. 2024 (€334 Mil) to Mar. 2025 (€260 Mil) but then increased from Mar. 2025 (€260 Mil) to Mar. 2026 (€544 Mil).

Advantest Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Advantest's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advantest Other Stockholders Equity Chart

Advantest Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 145.35 221.07 334.23 259.73 543.52

Advantest Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 259.73 289.03 335.65 476.69 543.52
FRA:VANA
87GF Score
Advantest Corp FRA:VANA
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Advantest Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €544 Mil mean?
Advantest (FRA:VANA) has a Other Stockholders Equity of €544 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Advantest and its competitors.
Is Advantest's Other Stockholders Equity too high?
Advantest's current Other Stockholders Equity is €544 Mil. Overall, Advantest has a GF Score™ of 87/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Advantest's Other Stockholders Equity compare to AMAT and LRCX?
Advantest's Other Stockholders Equity of €544 Mil can be compared against companies in the Semiconductors industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Semiconductors company?
A good Other Stockholders Equity depends on the Semiconductors industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Advantest and its competitors. Advantest's current Other Stockholders Equity is €544 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advantest stock overvalued right now?
Based on GuruFocus' analysis, Advantest (FRA:VANA) is currently considered Significantly Overvalued. The stock's GF Value™ is €84.37, compared to a current price of €167.00 — trading 97.9% above its estimated fair value. The current Other Stockholders Equity is €544 Mil. Advantest's overall GF Score™ is 87/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Advantest (FRA:VANA), the current Other Stockholders Equity is €544 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Advantest (FRA:VANA) Overvalued in 2026?

Based on GuruFocus' analysis, Advantest stock appears to be overvalued. The current stock price of €167.00 is trading 97.9% above its estimated GF Value™ of €84.37. GuruFocus considers Advantest to be Significantly Overvalued.

Key valuation signals for FRA:VANA:

  • Other Stockholders Equity: €544 Mil
  • GF Value™: €84.37 vs. price of €167.00 (97.9% above fair value)
  • GF Score™: 87/100 with 4 warning signs

No single metric tells the full story. See the FRA:VANA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Advantest Business Description

Address 1-6-2, Marunouchi, Shin-Marunouchi Center Building, Chiyoda-ku, Tokyo, JPN, 100-0005
Founded in 1954 and headquartered in Tokyo, Advantest specializes in semiconductor test systems and is a well-known leader in automated test equipment, or ATE. Advantest also has a high market share in test systems for nonmemory semiconductors, including application processors for mobile phones. The company is also involved in peripheral businesses, such as semiconductor device transport equipment. Following its acquisition of Verigy in July 2011, Advantest holds a market share of over 50% in the ATE market.
87GF Score

Get the complete analysis for FRA:VANA

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€167.00
Price
€84.37
GF Value